English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Arena Pharmaceuticals
Cheyenne Dickerson
| May 21, 2017
Arena Pharmaceuticals preparing to present ralinepag drug Phase 1 results
Carol Ostrow
| Feb 16, 2017
Arena presenting latest data on ulcerative colitis drug at summit
Carol Ostrow
| Jan 13, 2017
Eisai acquires rights to Lorcaserin HCI for weight control
Jeff Gantt
| Dec 24, 2016
ANVISA approves Belviq in Brazil
Carol Ostrow
| Dec 16, 2016
Arena Pharmaceuticals plans Jan. 12 webcast, conference presentation
Jeff Gantt
| Dec 14, 2016
Arena finalizes enrollment in ralinepag trial
Amanda Rupp
| May 26, 2016
Arena Pharmaceuticals welcomes new president, CEO
Trending
Patient Daily
| Aug 18, 2025
Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
Patient Daily
| Aug 21, 2025
SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’
Patient Daily
| Aug 21, 2025
Otolaryngologist on sinusitis and tooth pain: ‘Inflammation in the bottom of the sinus can cause sensitivity in the teeth’
+
Pharmaceuticals
Patient Daily
| Aug 21, 2025
PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program
